These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 417883)

  • 1. Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.
    Faglia G; Paracchi A; Ferrari C; Beck-Peccoz P
    Clin Endocrinol (Oxf); 1978 May; 8(5):373-80. PubMed ID: 417883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative persistent thyrotrophin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly.
    Biermasz NR; Smit JW; van Dulken H; Roelfsema F
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):313-9. PubMed ID: 11940042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L; Reschini E; Catania A; Giustina G
    Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postoperative basal serum GH level and the GH response to TRH in relation to the long-term outcome of surgical treatment for acromegaly: a report on 39 patients.
    Valdemarsson S; Bramnert M; Cronquist S; Elner A; Eneroth CM; Hedner P; Lindvall-Axelsson M; Nordström CH; Strömblad LG
    J Intern Med; 1991 Jul; 230(1):49-54. PubMed ID: 1906090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L; Mancini A; Zuppi P; Fiumara C; Iacona T; Conte G; Fabrizi ML; Valle D; Anile C; Maira G
    Minerva Chir; 1993 Nov; 48(21-22):1337-40. PubMed ID: 8152567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly.
    Arosio M; Giovanelli MA; Riva E; Nava C; Ambrosi B; Faglia G
    J Neurosurg; 1983 Sep; 59(3):402-8. PubMed ID: 6411870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
    Hanew K; Aida M; Tano T; Yoshinaga K
    Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
    Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
    Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients.
    Roelfsema F; van Dulken H; Frölich M
    Clin Endocrinol (Oxf); 1985 Nov; 23(5):555-65. PubMed ID: 4085133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The natural course of growth hormone-secreting pituitary adenomas after surgery alone--clinical significance of the growth hormone response to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone.
    Mukada K
    Neurol Med Chir (Tokyo); 1990 Apr; 30(4):251-7. PubMed ID: 1696695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin-C measurement in acromegaly.
    Losa M; Oeckler R; Schopohl J; Müller OA; Alba-Lopez J; von Werder K
    J Neurosurg; 1989 Apr; 70(4):561-7. PubMed ID: 2647918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
    Hulting AL; Theodorsson E; Werner S
    J Intern Med; 1992 Sep; 232(3):229-35. PubMed ID: 1402619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.
    Colao A; Merola B; Ferone D; Calabrese MR; Longobardi S; Spaziante R; Di Renzo G; Annunziato L; Lombardi G
    Eur J Endocrinol; 1994 Jul; 131(1):14-9. PubMed ID: 8038903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GHRF test in acromegalic patients for the evaluation of therapeutic results.
    Hanew K; Sato S; Sasaki A; Goh M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1985 Nov; 147(3):273-80. PubMed ID: 3937295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors determining the long-term outcome of surgery for acromegaly.
    Osman IA; James RA; Chatterjee S; Mathias D; Kendall-Taylor P
    QJM; 1994 Oct; 87(10):617-23. PubMed ID: 7987657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic hormone interaction in acromegaly.
    Gomez-Pan A; Tunbridge WM; Duns A; Hall R; Besser GM; Coy DH; Schally AV; Kastin AJ
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):455-60. PubMed ID: 170027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.